|Former: Atención Farmacéutica|
|Journal edited by Rasgo Editorial since 1983|
Maruxa Hernández Corredoira
EDITOR IN CHIEF
Manuela Velázquez Prieto
Tomás Casasín Edo
María B. Badía Tahull
Lluís Campins Bernadas
Juan Carlos Juárez Giménez
Carles Quiñones Ribas
Volume 23 - Issue 1, January-March 2021
CONVALESCENT PLASMA THERAPY FOR COVID-19: A REVIEW
ASMAA SALAH ELDIN MOHAMED, HOSAM MOHAMMAD AHMAD
Background: To date, no effective vaccine or drug treatment has been found against Coronavirus disease 2019 (COVID-19), but research indicates the effectiveness of plasma transfusion from patients that recovered from COVID-19 to another non recovered COVID-19 patient that is called convalescent plasma therapy. With the development of technical methods of plasma separation, screening and transfer, adverse reactions are few or rare. So, the hope remains to overcome the coronavirus pandemic using the plasma of the recovered patients. In this review, plasma therapy will be highlighted from multiple aspects to illustrate how important it is as an effective treatment against COVID-19.
Method: A narrative review of all the relevant papers after a thorough review of it.
Results: Convalescent plasma therapy is an effective therapy for treatment and prophylaxis for COVID-19.
Conclusion: Convalescent plasma from the recovered patients of COVID-19 can be effectively used as a treatment protocol and post-exposure prophylaxis alike.
ANTIBODIES – CONVALESCE NT PLASMA THERAP Y – COVID -19 – PASSIVE IMMUNIZATION